CN101432002B - 治疗慢性阻塞性肺疾病的方法和组合物 - Google Patents

治疗慢性阻塞性肺疾病的方法和组合物 Download PDF

Info

Publication number
CN101432002B
CN101432002B CN2007800071240A CN200780007124A CN101432002B CN 101432002 B CN101432002 B CN 101432002B CN 2007800071240 A CN2007800071240 A CN 2007800071240A CN 200780007124 A CN200780007124 A CN 200780007124A CN 101432002 B CN101432002 B CN 101432002B
Authority
CN
China
Prior art keywords
ether
chronic obstructive
obstructive pulmonary
pulmonary disease
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007800071240A
Other languages
English (en)
Chinese (zh)
Other versions
CN101432002A (zh
Inventor
上野隆司
久能祐子
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of CN101432002A publication Critical patent/CN101432002A/zh
Application granted granted Critical
Publication of CN101432002B publication Critical patent/CN101432002B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2007800071240A 2006-02-28 2007-02-27 治疗慢性阻塞性肺疾病的方法和组合物 Expired - Fee Related CN101432002B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77694306P 2006-02-28 2006-02-28
US60/776,943 2006-02-28
PCT/JP2007/054127 WO2007102446A2 (en) 2006-02-28 2007-02-27 Method and composition for treating chronic obstructive pulmonary disease

Publications (2)

Publication Number Publication Date
CN101432002A CN101432002A (zh) 2009-05-13
CN101432002B true CN101432002B (zh) 2012-04-04

Family

ID=38462529

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007800071240A Expired - Fee Related CN101432002B (zh) 2006-02-28 2007-02-27 治疗慢性阻塞性肺疾病的方法和组合物

Country Status (13)

Country Link
US (1) US20070203228A1 (enExample)
EP (1) EP1988905B1 (enExample)
JP (2) JP5377970B2 (enExample)
KR (1) KR101409706B1 (enExample)
CN (1) CN101432002B (enExample)
AR (1) AR059636A1 (enExample)
AU (1) AU2007223469B2 (enExample)
BR (1) BRPI0708362A2 (enExample)
CA (1) CA2642744C (enExample)
MX (1) MX2008011148A (enExample)
NZ (1) NZ571092A (enExample)
TW (1) TWI422368B (enExample)
WO (1) WO2007102446A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5377970B2 (ja) * 2006-02-28 2013-12-25 スキャンポ・アーゲー 慢性閉塞性肺疾患を処置するための方法および組成物
US20120309990A1 (en) * 2009-12-18 2012-12-06 Apotex Pharmachem Inc. Processes for the Purification of Lubiprostone
EP2699244A4 (en) * 2011-04-19 2014-10-22 Sucampo Ag METHOD FOR MODULATING CYTOKINACTIVITY
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430552A2 (en) * 1989-11-22 1991-06-05 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
US5739161A (en) * 1994-06-03 1998-04-14 R-Tech Ueno, Ltd. Agent for treating hepto.biliary diseases
EP0978284A1 (en) * 1997-11-28 2000-02-09 R-Tech Ueno, Ltd. Endothelin antagonist

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
US5362751A (en) * 1988-05-11 1994-11-08 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Tracheobronchodilator using 16-substituted PGEs
JPH0791192B2 (ja) * 1989-11-22 1995-10-04 株式会社上野製薬応用研究所 ガス交換機能不全処置剤
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
BR0107544A (pt) * 2000-04-06 2005-01-11 Sucampo Ag Composição de promoção de secreção de bile
MXPA04002006A (es) * 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
DE602004030245D1 (de) * 2003-07-03 2011-01-05 Sucampo Ag Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
JP5377970B2 (ja) * 2006-02-28 2013-12-25 スキャンポ・アーゲー 慢性閉塞性肺疾患を処置するための方法および組成物
EP2699244A4 (en) * 2011-04-19 2014-10-22 Sucampo Ag METHOD FOR MODULATING CYTOKINACTIVITY

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0430552A2 (en) * 1989-11-22 1991-06-05 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
US5739161A (en) * 1994-06-03 1998-04-14 R-Tech Ueno, Ltd. Agent for treating hepto.biliary diseases
EP0978284A1 (en) * 1997-11-28 2000-02-09 R-Tech Ueno, Ltd. Endothelin antagonist

Also Published As

Publication number Publication date
MX2008011148A (es) 2008-09-08
AU2007223469A1 (en) 2007-09-13
EP1988905A2 (en) 2008-11-12
NZ571092A (en) 2010-11-26
CA2642744A1 (en) 2007-09-13
TWI422368B (zh) 2014-01-11
KR20080104024A (ko) 2008-11-28
TW200800161A (en) 2008-01-01
AR059636A1 (es) 2008-04-16
US20070203228A1 (en) 2007-08-30
KR101409706B1 (ko) 2014-06-20
JP2009528259A (ja) 2009-08-06
AU2007223469B2 (en) 2012-06-07
WO2007102446A3 (en) 2008-04-03
CA2642744C (en) 2015-02-24
WO2007102446A2 (en) 2007-09-13
EP1988905B1 (en) 2014-06-04
CN101432002A (zh) 2009-05-13
JP5377970B2 (ja) 2013-12-25
BRPI0708362A2 (pt) 2011-05-24
JP2013209429A (ja) 2013-10-10

Similar Documents

Publication Publication Date Title
KR100750553B1 (ko) 외분비 장애 치료용 조성물
CN101432002B (zh) 治疗慢性阻塞性肺疾病的方法和组合物
JP5427029B2 (ja) 消化管の重炭酸分泌を促進するための方法および組成物
JP5294559B2 (ja) クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
AU2001239551B2 (en) Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
JP2010519177A (ja) ミトコンドリアを保護するための組成物および方法
JP2609479B2 (ja) カリウム排泄剤
JPWO1999018968A1 (ja) 門脈圧亢進抑制剤
JP2004521960A (ja) 高眼圧症および緑内障の処置のための方法および組成物
WO1999018968A1 (en) Portal hypertension inhibitor
JPH03163024A (ja) 高脂質血症処置・血中脂質成分低下剤
CN108685929A (zh) 用于治疗具有腹泻的肠易激综合征的方法
JPH03218315A (ja) ガス交換機能不全処置剤
JPH089544B2 (ja) 腸内排泄剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120404

Termination date: 20160227

CF01 Termination of patent right due to non-payment of annual fee